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Abstract
Purpose—The purpose of this study was to examine the relationship of perceived lung cancer 
stigma and timing of medical help-seeking behavior in symptomatic individuals.
Data sources—A convenience sample was recruited from an academic thoracic oncology clinic 
and community hospital-based outpatient radiation center in a large city in the southeastern United 
States. This descriptive, cross-sectional study used survey methodology and semi-structured 
interviews to examine the relationship of perceived lung cancer stigma and delayed medical help-
seeking finding a statistically significant positive correlation. Additional examination revealed 
positive correlations between the stigma and shame, social isolation, and smoking-related stigma 
subscales and delay. The discrimination-related subscale was not associated with delay. In 
addition, smoking status was not related to perceived lung cancer stigma.
Conclusions—Findings support an association between lung cancer stigma and delayed medical 
help-seeking behavior. Therefore, lung cancer stigma is a potential barrier to timely medical help-
seeking behavior in lung cancer symptoms, which can have important patient outcome 
implications.
Implications for practice—As primary care nurse practitioners, awareness that lung cancer 
stigma exists for patients is essential regardless of smoking status and efforts to decrease this 
barrier to timely healthcare are important.
Lung cancer kills more people than breast, colorectal, pancreatic, and prostate cancers 
combined regardless of gender or ethnicity (ACS, 2014). Lung cancer patients feel 
stigmatized reporting the highest levels of stigma and related psychological distress 
compared to all other cancers (Cataldo & Brodsky, 2013). In the United States, there will be 
an estimated 224,210 new cases and 159,260 lung cancer related deaths in 2014 (ACS, 
2014). Lung cancer-related mortality is directly related to stage at diagnosis and most are 
diagnosed at an advanced stage (Luo, Chen, Narsavage, & Ducatman, 2012). Individuals 
with Stage III and IV lung cancers have five-year survival rates of 5% and 1% respectively. 
Although individuals may be asymptomatic when diagnosed, many individuals do 
experience symptoms. An alarming proportion of symptomatic patients report varying 
degrees of delayed medical help-seeking behavior (Levealahti, Tishelman, & Ohlen, 2007). 
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When an individual has symptoms suggestive of lung cancer but waits to seek medical 
evaluation, lung cancer can advance exponentially (Salomaa, Sallinen, Hiekkanen, & 
Liippo, 2005). Perceived lung cancer stigma is a potential barrier to timely evaluation in 
symptomatic individuals. As primary care providers, nurse practitioners are frequently the 
first contact patients have with the healthcare system and are poised to address this 
important patient outcomes issue.
Stigma has historically been conceptualized by the seminal work of Goffman (1974) as “an 
attribute that links a person to an undesirable stereotype, leading other people to reduce the 
bearer from a whole and usual person to a tainted, discounted one” (p. 11). Lung cancer’s 
strong association with smoking has resulted in perceptions of self-infliction and subsequent 
stigma (Chapple, Ziebland, & McPherson, 2004). Stigmatized individuals suffer shame, an 
altered identity, and an associated blame (Engebretson, 2013). In fact, a lung cancer 
diagnosis can invoke similar attribution of blame as that seen with HIV/AIDS (Marlow, 
Waller, & Wardle, 2010). Over the past decade, the social stigma of smoking has become 
pronounced leading to negative attitudes held by both smokers and non-smokers (Raleigh, 
2010). Further, stigmatization from healthcare providers, family, and friends may be 
perceived by lung cancer patients regardless of the individual’s smoking status because the 
disease is so strongly associated with smoking (Cataldo, Jahan, & Pongquan, 2012). 
Because timely medical help-seeking behavior is critical in the lung cancer diagnostic 
process, the purpose of this study was to examine the relationship of perceived lung cancer 
stigma and timing of medical help-seeking behavior in symptomatic individuals.
Methods
Design
This descriptive, cross-sectional study assessed the correlation between perceived lung 
cancer stigma and timing of medical help-seeking behavior in symptomatic individuals. 
While the idea of medical help-seeking behavior in lung cancer symptoms is not new, 
exploring the relationship of perceived lung cancer stigma and medical help-seeking 
behavior has not been addressed in the current literature.
Theoretical Foundation
The “Model for Understanding Delayed Presentation with Breast Cancer” was the 
theoretical foundation for this study (Bish, Ramirez, Burgess, & Hunter, 2005). Bish and 
colleagues developed the model after exploring empirical evidence that suggested delayed 
medical help-seeking behavior was influenced by multiple complex interactions including 
sociodemographic, clinical, cognitive and behavioral variables. Specifically, 
sociodemographic variables (e.g. age, ethnicity, socioeconomic status, and access to medical 
care) influence knowledge and symptom appraisal, which influence attitudes to help seeking 
and disclosure of symptoms. Ultimately, these variables influence an individual’s intention 
to seek help and subsequent medical help-seeking behavior. In this study, perceived lung 
cancer stigma is conceptualized as a variable that influences both disclosure of symptoms 
and attitudes to medical help-seeking behavior.
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Participants were recruited from an academic thoracic oncology clinic and a community 
hospital-based outpatient radiation center in Louisville, Kentucky. At both recruitment sites, 
the setting was a private exam room within the clinic.
Procedures
Participant Recruitment and Screening
The University of Louisville Institutional Review Board, Clinical Scientific Review 
Committee at the James Graham Brown Cancer Center, and the Nursing Research 
Committee at Baptist Healthcare reviewed and approved the study prior to recruitment. All 
participants gave written informed consent prior to data collection. Inclusion criteria 
included diagnosis of non-small cell lung cancer as the primary site of cancer and 
knowledge of stage at diagnosis. Only adult (age 22 and older), English-speaking patients 
were invited to participate. A convenience sample of 93 participants was recruited from the 
94 eligible participants. Study recruitment took place from December 2012 to February 
2013. The researcher worked with clinic nursing staff to identify potential participants at the 
start of each clinic day. All (N = 94) were approached by the lung oncologist, nurse 
practitioner, or nurse during a follow-up appointment and introduced to the study 
opportunity. If the potential participant was interested in receiving further information, the 
researcher was invited into the exam room to explain the study fully and answer all 
questions. The researcher was not employed by either recruitment site. Informed consent 
was obtained and data collected.
Data Collection
Data were collected using survey methodology and a semi-structured interview. The 31-item 
four-point Likert style Cataldo Lung Cancer Stigma Scale (CLCSS) is a survey developed 
by Cataldo and colleagues (2011) to measure perceived lung cancer stigma in people with 
lung cancer with components that focus on stigma and shame, social isolation, 
discrimination, and smoking. Statements such as “I feel guilty because I have lung cancer”; 
“My lung cancer diagnosis was delayed because my healthcare provider did not take my 
smoker’s cough seriously”; and “Others assume that a patient’s lung cancer was caused by 
smoking, even if he or she never smoked” comprise the CLCSS (Cataldo et al., 2011). 
Participants were asked to respond to each statement with either strongly agree, agree, 
disagree, or strongly disagree. Timing of medical help-seeking behavior was defined as the 
number of days between the first symptom(s) and the time the individual called their 
primary care provider to seek evaluation for those symptoms. For the purposes of this paper, 
the number of days was used in the analyses. The qualitative analysis will be reported 
separately and is not included in this paper. Timing data was gathered retrospectively as 
self-report. Although few individuals had difficulty recalling initial symptoms and 
associated dates, for those that did, key event mapping was used in which recall was 
enhanced using a calendar and reference to common and participant specific dates and times 
of the year (Molassiotis, Wilson, Brunton, & Chandler, 2010). Using G*Power 3.14, a 
sample of 93 provided a power of 0.72 to identify a medium effect size (Cohen’s d = 0.3) 
using three groups and a .05 level of significance (Faul, Erdfelder, Lang, & Buchner, 2009).
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Data were analyzed using the Statistical Package for Social Sciences (IBM Corp, 2012). 
Descriptive statistics, Pearson product-moment correlations, and one-way analysis of 
variance were employed to evaluate the data. The criterion for statistical significance was p 
≤ .05 for all statistical tests.
Results
Sample Characteristics
The majority of participants were Caucasian, female, educated, and insured. The mean age 
of the sample was 62 years (SD = 8.7). The ethnic representation of the sample closely 
mirrored that of the geographic location with 77 (82.8%) Caucasian and 16 (17.2%) African-
American participants. Most participants were advanced stage; 29 (31.2%) were Stage III 
and 43 (46.2%) were Stage IV at diagnosis. A full description of sample characteristics can 
be found in Table 1.
Timing of Medical Help-Seeking Behavior
Preliminary analyses were performed to ensure no violation of the assumptions of normality, 
linearity and homoscedasticity. The variable, timing of medical help-seeking behavior, was 
positively skewed. A log transformation was applied and resolved the violation to the 
assumption of normality. The median number of days reported between the first symptom(s) 
and the time the individual called their primary care provider to seek evaluation for those 
symptoms was 41 days. Participants reported a range of 0 to 366 days to seek medical 
evaluation.
Perceived Lung Cancer Stigma
Total perceived lung cancer stigma scores were measured with the CLCSS in which total 
scores range from 31–124. Higher scores reflect higher levels of perceived lung cancer 
stigma. Total perceived lung cancer stigma in this sample ranged from 31–98 (mean 68.6; 
SD 11.5) and the scale Cronbach’s alpha was .95 consistent with excellent internal 
consistency reliability. The CLCSS is comprised of four subscales: (1) stigma and blame; 
(2) social isolation; (3) discrimination; and, (4) smoking. Stigma and blame subscale scores 
range from 11–34; the mean stigma and blame subscale scores in this sample were 23.6 (SD 
4.2). Social isolation-related stigma subscale scores range from 10–30; the mean social 
isolation-related stigma scores in this sample were 20.1 (SD 3.95). Discrimination-related 
stigma subscale scores range from 5–16; the mean discrimination-related stigma scores in 
this sample were 10.4 (SD 2.0). Smoking-related stigma subscale scores range from 5–20; 
the mean smoking-related stigma scores in this sample were 14.5 (SD 3.1).
The relationship between the total and subscale stigma scores and timing of medical help-
seeking behavior in symptoms suggestive of lung cancer were investigated using the 
Pearson product-moment correlation coefficient. There was a small, positive correlation 
between total perceived lung cancer stigma scores and timing of medical help-seeking 
behavior, r = .27, n = 93, p = .01, with high levels of perceived lung cancer stigma 
associated with an increased number of days to seek medical help for symptoms suggestive 
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of lung cancer. In addition, the relationship between the individual stigma-related subscales 
of the CLCSS and timing of medical help-seeking behavior were examined to understand 
the descriptive data more completely. There were small, positive correlations noted 
individually between the stigma and blame, social isolation, and smoking-related subscales 
and timing of medical help-seeking behavior (see Table 2). However, there was not a 
statistically significant relationship between the discrimination-related stigma subscale and 
timing of medical help-seeking behavior, r = .18, p = .09.
We also examined the difference in perceived lung cancer stigma scores by smoking status. 
A one-way between-groups analysis of variance was conducted to explore the impact of 
smoking status at lung cancer diagnosis on perceived lung cancer stigma, as measured by the 
total CLCSS scores. Participants were classified as never smokers, former smokers, or 
current smokers by self-report. There was no statistically significant difference at the p < .05 
level in total perceived lung cancer stigma scores for the three smoking status groups: F (2, 
90) = .14, p = .87.
Conclusions
Perceived lung cancer stigma was associated with delays in medical help-seeking behavior. 
When perceived lung cancer stigma was examined using the CLCSS subscales, the 
constructs of importance were shame and stigma, social isolation, and smoking-related 
stigma. Most importantly, perceived lung cancer stigma scores did not differ by smoking 
status.
Discussion
Although timing of medical help-seeking behavior ranged widely from immediate medical 
help-seeking behavior (0 days) to lengthy delays (366 days), the median of 41 days suggests 
symptomatic individuals are waiting to seek medical evaluation for symptoms of concern. 
Patient delay has been defined as three months or longer in other cancers (Bish et al., 2005). 
However, given the high mortality related to lung cancer, defining patient delay in lung 
cancer by the same three-month measure may not be appropriate. Individuals with 
symptoms suggestive of lung cancer should be evaluated promptly.
Perceived lung cancer stigma in patients that have symptoms suggestive of lung cancer can 
serve as a critical barrier to timely medical help-seeking behavior. When an individual 
becomes aware of a symptom of concern but delays seeking evaluation because of the fear 
of feeling stigmatized, lung cancer has the potential to advance. As primary care providers, 
nurse practitioners are key in the assessment and diagnosis of symptoms that may ultimately 
be lung cancer. It is imperative for primary care nurse practitioners to address lung cancer 
stigma in practice to combat this barrier to timely medical help-seeking behavior.
Lung cancer stigma is a national health issue with multiple layers of complexity. This 
important public health issue must be addressed from individual-, provider- and system-
level perspectives. Some practical recommendations that may begin to address lung cancer 
stigmatization include (1) provider self-awareness; (2) education (patient, public and policy 
leader); (3) community engagement; and, (4) patient advocacy.
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Because lung cancer stigma is so deeply rooted in society, providers are not immune to the 
subtle negative assumptions related to individuals with lung cancer that can negatively 
impact the patient-provider relationship. This societal entrenchment of stigma surrounding 
lung cancer necessitates provider self-awareness to begin to address this problem. Lung 
cancer is not a smoker exclusive disease. While tobacco cessation is important and screening 
for lung cancer in high-risk, long-term smokers is essential, the historical evolution of 
smoking and lung cancer has led to the unfortunate stigmatization of the deadliest cancer in 
the world. It is essential to increase awareness in the primary care community that lung 
cancer stigma exists with patients regardless of smoking status. Increased awareness will 
challenge providers to reassess their assumptions that may negatively and unknowingly 
impact the patient-provider relationship in the clinical setting. Self-awareness as a provider 
of negative assumptions related to lung cancer can positively impact future patient-provider 
encounters.
Lung cancer-related stigma arises from a belief that a person caused his or her own cancer 
(i.e. from smoking). A key to combat lung cancer-related stigma is to educate patients, and 
by doing so the public, about common lung cancer symptoms (i.e. persistent or increased 
cough, fatigue, chest discomfort, unexplained weight loss, hemoptysis), risk factors and 
prevalence of lung cancer in never and former smokers. By educating patients about non-
smoking related risk factors such as radon and occupational environmental exposure, we can 
start to address the myth of lung cancer as a smoker exclusive disease and indirectly address 
self-infliction blame.
Further, community engagement of the issue of lung cancer is paramount. While most lung 
cancer patients are diagnosed at an advanced stage, there are lung cancer survivors. Often, 
the general public is not aware because they do not routinely see the face of lung cancer. A 
concerted effort needs to prominently engage lung cancer survivors in community events to 
raise awareness about lung cancer in order to fight its related stigma. For example, 
highlighting a lung cancer survivor during a local community outreach effort on cancer 
awareness will serve to promote education, awareness, and give a relatable face to lung 
cancer.
Finally, as nurse practitioners, it is our responsibility to be educated about the disease and 
educate others, but to also advocate for lung cancer patients and a reduction in its associated 
stigma. On a broader level, we are uniquely poised to educate state and federal policy 
leaders on the need for increased resources for lung cancer research. Policy leaders must 
know this issue is important to the nurse practitioner community. Resources specific to 
targeting lung cancer stigma in addition to prevention, early detection, and treatment are 
key. It is critical to acknowledge that current healthcare system constraints imposed by 
policy may hinder efforts to employ ideal practice making patient advocacy in this area 
essential. In order to move the agenda of decreasing lung cancer stigma forward, health 
policy must be shaped by healthcare providers for meaningful healthcare change to occur.
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As with all studies, this study is not without limitations. The greatest limitation involves the 
potential for recall bias. Data was collected retrospectively regarding symptom awareness 
and the time from symptom onset to medical help-seeking behavior. Key event mapping was 
used to increase the accuracy of recall. Although most participants did not have difficulty 
recalling specific symptoms and time periods, key event mapping was successful in those 
that needed assistance. In addition, the relatively small sample size of 93 participants limited 
power reached for this study and the ability to generalize. Future studies should be 
performed with a larger sample to assess replication of findings. Finally, the average age of 
study participants was nearly a decade younger than the average lung cancer patient in the 
United States. Younger individuals may perceive lung cancer stigma differently than older 
individuals. Future studies should aim to recruit a sample representative in age of the 
national lung cancer patient population.
Implications
When patients perceive lung cancer stigma, they may not seek help in a timely manner with 
initial symptoms. Delayed medical help-seeking behavior may result in an advanced stage 
lung cancer diagnosis, which is associated with a decreased prognosis secondary to 
decreased treatment options. With the recent release of lung cancer screening guidelines for 
high-risk patients by the United States Preventive Services Task Force (Moyer, 2013), 
perceived lung cancer stigma may negatively impact screening participation. Decreased 
screening participation secondary to lung cancer stigma may be associated with more 
advanced stage diagnoses compared to the potential for earlier stage diagnosis discovered by 
screening participation. Lung cancer stigma can also affect the patient-provider relationship 
which can compromise trust in other health-related areas such as seeking medical evaluation 
for other symptomatic conditions, adhering to healthcare recommendations, and keeping 
scheduled follow-up appointments. Going forward, primary care nurse practitioners will be 
an integral component of a public health awareness effort and paradigm shift related to 
perceived lung cancer stigma and its impact on patient outcomes.
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 Male 35 (37.6)
 Female 58 (62.4)
Ethnicity
 Caucasian 77 (82.8)
 African-American 16 (17.2)
Education
 Less than High School 3 (3.2)
 High School Graduate 37 (39.8)
 Some College 20 (21.5)
 College Graduate or Higher 33 (35.5)
Marital Status
 Not Married/Separated 33 (35.5)
 Married 60 (64.5)
Employment Status
 Employed 26 (28.0)
 Unemployed/Retired 67 (72.0)
Insurance Status
 Medicare/Medicaid 41 (44.0)
 Private Health Insurance 40 (43.0)
 Uninsured 12 (12.9)
Stage at Diagnosis:
 Stage I 7 (7.5)
 Stage II 14 (15.1)
 Stage III 29 (31.2)
 Stage IV 43 (46.2)
Smoker at Diagnosis
 Yes 30 (32.3)
 No 63 (67.7)
Smoking Status
 Never Smoker 30 (32.3)
 Former Smoker 33 (35.5)
 Current Smoker 30 (32.3)
Do you now smoke?
 Every Day 6 (6.5)
 Some Days 4 (4.3)
 Not at All 53 (57.0)
How long since last smoked regularly?
 Within the past month 12 (12.9)












 Within the past 3 months 3 (3.2)
 Within the past 6 months 5 (5.4)
 Within the past year 4 (4.3)
 Within the past 5 years 8 (8.6)
 Within the past 10 years 10 (10.8)
 10 years or more 21 (22.6)
Packs per day (PPD) of current smokers at diagnosis
 Less than 1 PPD 5 (5.4)
 1 PPD 12 (12.9)
 1.5 PPD 1 (1.1)
 2 PPD 10 (10.8)
 3 PPD 2 (2.2)











Correlations, means and standard deviations on subscale values
Measure Mean SD r
Stigma and Blame 23.6 4.20
.26*




Discrimination 10.4 2.00 .18
*p < .05
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